TransMedics Group

ISIN US89377M1099

 | 

WKN A2PH5P

Market cap (in EUR)
3,876 m
Country
United States
Sector
Healthcare
Dividend yield
0.00%
 

Overview

Description

TransMedics Group, Inc. operates as a commercial stage medical technology company. The firm engages in the development and commercialization of organ care system platform. It focuses on the preservation of human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation. The company was founded by Waleed H. Hassanein in August 1998 and is headquartered in Andover, MA.
Show more Show less
Healthcare Healthcare Equipment Other Medical Devices United States

Financials

Key metrics

Market capitalisation, EUR 3,876 m
EPS, EUR 2.24
P/B ratio 12.8
P/E ratio 53.6
Dividend yield 0.00%

Income statement (2024)

Revenue, EUR 408 m
Net income, EUR 33 m
Profit margin 8.03%

What ETF is TransMedics Group in?

There are 4 ETFs which contain TransMedics Group. All of these ETFs are listed in the table below. The ETF with the largest weighting of TransMedics Group is the iShares S&P SmallCap 600 UCITS ETF.
ETF Weight Investment focus Fund size (in m EUR)
iShares S&P SmallCap 600 UCITS ETF 0.32%
Equity
United States
Small Cap
1,769
Vanguard ESG Global All Cap UCITS ETF (USD) Distributing 0.00%
Equity
World
Social/Environmental
494
Vanguard ESG North America All Cap UCITS ETF (USD) Distributing 0.01%
Equity
North America
Social/Environmental
27
JPMorgan BetaBuilders US Small Cap Equity UCITS ETF USD (dist) 0.07%
Equity
United States
Small Cap
183
— Data provided by Trackinsight, etfinfo, Xignite Inc., gettex, FactSet and justETF GmbH.

Quotes are either real-time (gettex) or 15 minutes delayed stock exchange quotes or NAVs (daily published by the fund provider). By default, ETF returns include dividend payments (if applicable). There is no warranty for completeness, accuracy and correctness for the displayed information.